Advanced Medical Solutions Group Management
Management criteria checks 4/4
Advanced Medical Solutions Group's CEO is Chris Meredith, appointed in Jan 2011, has a tenure of 13.83 years. total yearly compensation is £813.00K, comprised of 46.6% salary and 53.4% bonuses, including company stock and options. directly owns 0.83% of the company’s shares, worth £3.82M. The average tenure of the management team and the board of directors is 4.8 years and 3.8 years respectively.
Key information
Chris Meredith
Chief executive officer
UK£813.0k
Total compensation
| CEO salary percentage | 46.6% |
| CEO tenure | 13.8yrs |
| CEO ownership | 0.8% |
| Management average tenure | 4.8yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
Advanced Medical Solutions Group plc's (LON:AMS) Popularity With Investors Is Under Threat From Overpricing
Nov 18
A Look At The Fair Value Of Advanced Medical Solutions Group plc (LON:AMS)
Sep 07Should You Be Adding Advanced Medical Solutions Group (LON:AMS) To Your Watchlist Today?
Nov 03Advanced Medical Solutions Group plc (LON:AMS) Shares Could Be 38% Below Their Intrinsic Value Estimate
Sep 05Advanced Medical Solutions Group (LON:AMS) Will Want To Turn Around Its Return Trends
Dec 03Are Investors Undervaluing Advanced Medical Solutions Group plc (LON:AMS) By 23%?
Sep 03Advanced Medical Solutions Group's (LON:AMS) Returns On Capital Not Reflecting Well On The Business
Aug 05An Intrinsic Calculation For Advanced Medical Solutions Group plc (LON:AMS) Suggests It's 33% Undervalued
May 31Advanced Medical Solutions Group (LON:AMS) May Have Issues Allocating Its Capital
Apr 23Advanced Medical Solutions Group (LON:AMS) Might Be Having Difficulty Using Its Capital Effectively
Jan 08A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Nov 24Some Investors May Be Worried About Advanced Medical Solutions Group's (LON:AMS) Returns On Capital
May 22A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Apr 10Results: Advanced Medical Solutions Group plc Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 20Should Advanced Medical Solutions Group (LON:AMS) Be Disappointed With Their 30% Profit?
Feb 28The Returns At Advanced Medical Solutions Group (LON:AMS) Provide Us With Signs Of What's To Come
Feb 07
Advanced Medical Solutions Group plc's (LON:AMS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 18How Much Is Advanced Medical Solutions Group plc (LON:AMS) Paying Its CEO?
Dec 28Calculating The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Dec 10The Advanced Medical Solutions Group (LON:AMS) Share Price Is Up 38% And Shareholders Are Holding On
Nov 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | UK£11m |
| Mar 31 2024 | n/a | n/a | UK£14m |
| Dec 31 2023 | UK£813k | UK£379k | UK£16m |
| Sep 30 2023 | n/a | n/a | UK£18m |
| Jun 30 2023 | n/a | n/a | UK£20m |
| Mar 31 2023 | n/a | n/a | UK£20m |
| Dec 31 2022 | UK£832k | UK£339k | UK£20m |
| Sep 30 2022 | n/a | n/a | UK£19m |
| Jun 30 2022 | n/a | n/a | UK£18m |
| Mar 31 2022 | n/a | n/a | UK£18m |
| Dec 31 2021 | UK£543k | UK£329k | UK£17m |
| Sep 30 2021 | n/a | n/a | UK£16m |
| Jun 30 2021 | n/a | n/a | UK£14m |
| Mar 31 2021 | n/a | n/a | UK£11m |
| Dec 31 2020 | UK£537k | UK£305k | UK£9m |
| Sep 30 2020 | n/a | n/a | UK£11m |
| Jun 30 2020 | n/a | n/a | UK£14m |
| Mar 31 2020 | n/a | n/a | UK£16m |
| Dec 31 2019 | UK£770k | UK£300k | UK£19m |
| Sep 30 2019 | n/a | n/a | UK£20m |
| Jun 30 2019 | n/a | n/a | UK£21m |
| Mar 31 2019 | n/a | n/a | UK£22m |
| Jan 01 2019 | n/a | n/a | UK£22m |
| Sep 30 2018 | n/a | n/a | UK£22m |
| Jun 30 2018 | n/a | n/a | UK£22m |
| Mar 31 2018 | n/a | n/a | UK£21m |
| Dec 31 2017 | UK£1m | UK£270k | UK£20m |
Compensation vs Market: Chris's total compensation ($USD1.02M) is about average for companies of similar size in the UK market ($USD983.02K).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
CEO
Chris Meredith (58 yo)
13.8yrs
Tenure
UK£813,000
Compensation
Mr. Andrew Christopher Meredith, also known as Chris, B.Sc. (Hons.) has been the Chief Executive Officer of Advanced Medical Solutions Group plc since January 2011 and served as Chief Operating Officer sin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 13.8yrs | UK£813.00k | 0.83% £ 3.8m | |
| CFO & Executive Director | 5.8yrs | UK£415.00k | 0.078% £ 356.5k | |
| Group Operations Director | less than a year | no data | no data | |
| Investor Relations Manager | no data | no data | no data | |
| Head of Legal | no data | no data | no data | |
| Group Human Resources Director | 7.5yrs | no data | no data | |
| Chief Commercial Officer | less than a year | no data | no data | |
| Company Secretary | 3.8yrs | no data | no data |
4.8yrs
Average Tenure
Experienced Management: AMS's management team is considered experienced (4.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 18.6yrs | UK£813.00k | 0.83% £ 3.8m | |
| CFO & Executive Director | 5.8yrs | UK£415.00k | 0.078% £ 356.5k | |
| Senior Independent Non-Executive Director | 3.8yrs | UK£57.00k | no data | |
| Independent Non-Executive Director | 3.3yrs | UK£54.00k | no data | |
| Independent Non-Executive Chairman | 2.3yrs | UK£46.00k | 0.025% £ 115.1k |
3.8yrs
Average Tenure
58yo
Average Age
Experienced Board: AMS's board of directors are considered experienced (3.8 years average tenure).